Autor: |
Choi, David K., Martin, Michelle T., Chacra, Wadih, Chan, Christine, Koppe, Sean, Landers, Lisa, Naveed, Ammara, Mikolajczyk, Adam E. |
Předmět: |
|
Zdroj: |
International Journal of Clinical Pharmacy; Jun2021, Vol. 43 Issue 3, p753-755, 3p |
Abstrakt: |
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|